Monopar Therapeutics Inc banner

Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 56.26 USD 1.9% Market Closed
Market Cap: $375.8m

During the last 3 months Monopar Therapeutics Inc insiders bought 104.9k USD , and have not sold any shares. The stock price has dropped by 21% over this period (open performance analysis).

The last transaction was made on Dec 26, 2025 by Vu Quan Anh , who bought 104.9k USD worth of MNPR shares.

Last Transactions:
Vu Quan Anh
$+104.9k
Klausner Arthur J
$-312.5k
Brown Michael J
$-35m
Tsuchimoto Kim R
$-356.2k
Robinson Chandler
$-672k
Starr Christopher M
$-672k
Brown Michael J
$-1.2m
Radhakrishnan Karthik
$+25.2k
Cittadine Andrew
$+3.1k
Cittadine Andrew
$+2.1k
Cittadine Andrew
$+2.2k
Cittadine Andrew
$+2.2k
Cittadine Andrew
$+2.2k
Cittadine Andrew
$+1.9k
Cittadine Andrew
$+1.8k
Cittadine Andrew
$+1.5k
Cittadine Andrew
$+1.5k
Cittadine Andrew
$+1.5k
Cittadine Andrew
$+6.3k
Cittadine Andrew
$+3.6k
Brown Michael J
$-113k
Hendricks Diane
$+750k
Leo Karl
$+250k
Tsuchimoto Kim R
$+520
Tactic Pharma Llc
$+200k
View All Transactions

During the last 3 months Monopar Therapeutics Inc insiders bought 104.9k USD , and have not sold any shares. The stock price has dropped by 21% over this period (open performance analysis).

The last transaction was made on Dec 26, 2025 by Vu Quan Anh , who bought 104.9k USD worth of MNPR shares.

Sold
0-3
months
0 USD
0
3-6
months
312.5k USD
1
6-9
months
36.7m USD
4
9-12
months
1.2m USD
1
Bought
0-3
months
1
104.9k USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Monopar Therapeutics Inc
Insider Trading Chart

Monopar Therapeutics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Monopar Therapeutics Inc
Last Insider Transactions

Global
Insiders Monitor

Monopar Therapeutics Inc
Glance View

Market Cap
375.8m USD
Industry
Biotechnology

Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Wilmette, Illinois and currently employs 9 full-time employees. The company went IPO on 2019-12-19. The firm is primarily focused on developing therapeutics designed for cancer patients. Its product pipeline includes Validive, camsirubicin, MNPR-101, and MNPR-202. The Validive is a first-in-class mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis (SOM) in oropharyngeal cancer patients. Its camsirubicin is a clinical stage topoisomerase II-alpha selective novel analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart. Its MNPR-101 is a humanized monoclonal antibody designed to bind a specific cell surface receptor found on cancer cells, the urokinase plasminogen activator receptor (uPAR), and to interrupt several pathways required for tumor growth and progression. The MNPR-202 is an early stage camsirubicin analog for various cancers.

MNPR Intrinsic Value
15.97 USD
Overvaluation 72%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett